Antimicrobial agent Percentage (%) of Isolates
Susceptible Intermediate Resistant
CSE1034 92.3 7.7 -
Ceftriaxone 30.7 15.4 53.8
Cefoperazone+sulbactam 38.4 23.0 38.4
Meropenem 61.5 23.0 15.4
Piperacillin plus tazobactam 46.1 23.0 30.7
Amoxycillin plus clavulanic acid 30.7 23.0 46.3
Table 2: AST of the curli positive E. coli clinical isolates.